Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
670,950,352
-
Share change
-
+79,040,952
-
Total reported value
-
$11,466,263,858
-
Put/Call ratio
-
163%
-
Price per share
-
$17.09
-
Number of holders
-
496
-
Value change
-
+$1,343,704,129
-
Number of buys
-
189
-
Number of sells
-
247
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2018
As of 31 Mar 2018,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
496 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
670,950,352 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, Berkshire Hathaway Inc, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, HIGHFIELDS CAPITAL MANAGEMENT LP, BlackRock Inc., Northern Cross, LLC, FMR LLC, and JPMORGAN CHASE & CO.
This page lists
497
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.